GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75F40120C00060TOXICOLOGIC PATHOLOGY ASSOCIATES INC

Overview

Award facts

Net obligations
$23.90M
$23,901,717of $24.58M potential value
Outlays (paid to date)
$19.12M
$19.12M paid of $23.90M obligated$19,120,164
Period of performance
Jul 14, 2020 to Sep 15, 2025
Ended
Modifications
20
Latest action Dec 29, 2025
Contract type
Definitive contract
PIID 75F40120C00060

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

ON-SITE PATHOLOGY SERVICES

Dates and value

Award date
Signed on Jul 14, 2020
Potential end of performance
Sep 14, 2025
Current value
$24,579,600Base and exercised options
Potential value (if all options are exercised)
$24,579,600

Obligations by fiscal year of action

  • FY2026: -$218,910 (de-obligation)
  • FY2025: $1,026,996
  • FY2024: $4,828,602
  • FY2023: $4,684,717
  • FY2022: $4,848,584
  • FY2021: $4,366,075
  • FY2020: $4,365,653

Total across 7 fiscal years: $23,901,717

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 29, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationFREDERICK, MD
UEIPMMBWH3UHBV7
CAGE code30PB0
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Human drugs; National center for toxicological research; Fda other activities (fda headquaters); Fda user fees (non general fund); Fda reimbursable program (federal sources)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Jefferson, Arkansas 72079-0001
Congressional district (place of performance)
AR-04As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
Q515MEDICAL- PATHOLOGY (service)

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Small business set aside - totalSBA
Contract pricing
Labor hoursZ
Offers received
1

Solicitation and notices

Solicitation ID
FDA-SOL-128123(as reported)
Solicitation date
Apr 20, 2020

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Service Contract Act labor standards
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction uses GFE/GFPY
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jul 14, 2020Base obligation at award: $3,782,653
Latest action
Dec 29, 2025 — CloseoutModification P00020; obligation change -$218,910; administrative: no change in scope or value
Latest substantive action
Jul 18, 2025 — Option exercisedModification P00019; obligation change +$836,042
Latest funding action
Jun 15, 2022 — Funding onlyModification P00009; obligation change +$186,000; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Option exercised8
  • Funding only5
  • Supplemental agreement (within scope)3
  • Other administrative action3
  • Closeout1
21 actions recorded, Jul 14, 2020 to Dec 29, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$218,910
Latest action: change in base and all options
-$218,910

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
Yes
Walsh-Healey Act (materials and supplies)
Yes
Construction wage rates (Davis-Bacon)
Yes

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
21

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2020/2020-0600-000
  • 075-2021/2021-0600-000
  • 075-2022/2022-0600-000
  • 075-2023/2023-0600-000
  • 075-2024/2024-0600-000
  • 075-2025/2025-0600-000
Show all 7 accounts
  • 075-X-0600-000
Object classes
  • 21.0: Travel and transportation of persons
  • 25.4: Operation and maintenance of facilities
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression